Available in:
- 250 mg per 5 mL single-dose syringes
Benefits:
- DEHP-free
- PVC-free
- Not made with natural rubber latex
- AO Rated
Downloads:
FULVESTRANT Injection
Brand Name Equivalent: FASLODEX® (FASLODEX is a registered trademark of AstraZeneca UK Limited Company)
Therapeutic Category: Antineoplastic Agent
PreventIV Measures® Features:
- Easy-to-read drug name and dosage strength to aid in identifying the right product
- Bar codes included on the syringe and carton for ease of scanning
- Unique label design to help products stand out on the shelf
- Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
| NDC #25021 |
Description | Strength | Fill Volume |
Concentration | Container Size |
Closure | Unit of Sale |
| 462-74 | Prefilled Syringe | 250 mg | 5 mL | 50 mg per mL | N/A | Luer | 2 |